Tan Y, Lu J, Zhang J, Qi X, et al. Efgartigimod-rituximab sequential therapy in Anti-NMDAR encephalitis: real-world evidence for a novel salvage-maintenance strategy. J Neurol 2025;272:739.
PMID: 41160192